These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1864227)

  • 1. Topical application of superoxide dismutase cream.
    Mizushima Y; Hoshi K; Yanagawa A; Takano K
    Drugs Exp Clin Res; 1991; 17(2):127-31. PubMed ID: 1864227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary study of the therapeutic effect of superoxide dismutase in 7 cases of Behçet's disease].
    Emerit J; Jeny C; Emerit I; Le Hoang P; Caen OL; Pelletier S; Mollet M; Congy F
    C R Acad Sci III; 1986; 302(7):243-6. PubMed ID: 3084046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
    Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
    J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pimecrolimus 1% cream for cutaneous lupus erythematosus.
    Kreuter A; Gambichler T; Breuckmann F; Pawlak FM; Stücker M; Bader A; Altmeyer P; Freitag M
    J Am Acad Dermatol; 2004 Sep; 51(3):407-10. PubMed ID: 15337984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of interferon-gamma containing gel for local treatment of skin ulcers in autoimmune vasculitides and skin changes in progressive systemic sclerosis.
    Arnaudova P; Rashkov R; Tsanev R
    J Rheumatol; 1993 Aug; 20(8):1445-6. PubMed ID: 8230042
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of collagenoses with cytostatic agents].
    Klabusay L
    Vnitr Lek; 1980 Oct; 26(10):941-6. PubMed ID: 6110279
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thalidomide--a new prospective therapy in rheumatology and transplantation].
    Pałgan K; Pałgan I; Dziedziczko A
    Wiad Lek; 2003; 56(11-12):574-6. PubMed ID: 15058168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid peroxides and superoxide dismutase (SOD) induction in skin inflammatory diseases, and treatment with SOD preparations.
    Niwa Y
    Dermatologica; 1989; 179 Suppl 1():101-6. PubMed ID: 2673851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of collagen diseases].
    Calin A
    Internist (Berl); 1980 Nov; 21(11):697-701. PubMed ID: 7005164
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study.
    Niwa Y; Somiya K; Michelson AM; Puget K
    Free Radic Res Commun; 1985; 1(2):137-53. PubMed ID: 3880279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo.
    Sanclemente G; Garcia JJ; Zuleta JJ; Diehl C; Correa C; Falabella R
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1359-64. PubMed ID: 18624857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current aspects of immunosuppressive therapy of collagen diseases].
    Marmont A; Rossi F; Bordo D
    Minerva Med; 1973 Jun; 64(46):2436-50. PubMed ID: 4723570
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of systemic lupus erythematosus and systemic scleroderma with heparin].
    Gorbunova ZV; Iakimova NIa; Sukhanov AA; Grinberg NB
    Klin Med (Mosk); 1974; 52(8):55-8. PubMed ID: 4418071
    [No Abstract]   [Full Text] [Related]  

  • 14. Current trends in dermatology.
    Pirozzi DJ
    J Med Assoc Ga; 1980 May; 69(5):345-9. PubMed ID: 7373172
    [No Abstract]   [Full Text] [Related]  

  • 15. Histological observation of the submandibular gland with special reference to the focal lymphocytic infiltration.
    Nasu M
    Bull Tokyo Med Dent Univ; 1982 Dec; 29(4):139-52. PubMed ID: 6959739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuromuscular complications of long-term treatment of inflammatory diseases. 3 cases].
    Tattevin P; Arondelle C; Margent P; Broucker De T
    Ann Med Interne (Paris); 1999 Dec; 150(8):594-7. PubMed ID: 10686640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of collagen diseases--a questionnaire survey in Japan (author's transl)].
    Nobunaga M; Shiokawa Y
    Ryumachi; 1980 Jun; 20(3):140-50. PubMed ID: 7414429
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunosuppressive treatment of collagen diseases].
    Cruchaud A
    Ther Umsch; 1969 Dec; 26(12):697-702. PubMed ID: 5386688
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic possibilities in chronic connective tissue diseases in ambulatory and stationary care].
    Sönnichsen N
    Dermatol Wochenschr; 1967 Dec; 153(52):1417-25. PubMed ID: 5589734
    [No Abstract]   [Full Text] [Related]  

  • 20. A primer of collagen disease.
    Tuffanelli DL
    Minn Med; 1974 Oct; 57(10):798-808, 820. PubMed ID: 4608343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.